Cargando…

A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma

There have been extensive efforts to improve the outcome of glioblastoma, but the prognosis of this disease has not been significantly altered to date. Histone deacetylase inhibitors (HDACIs) have been evaluated as promising anti-cancer drugs and regulate cell growth, cell cycle arrest and apoptosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Seung Ah, Kwak, Pil Ae, Park, Chul-Kee, Wang, Kyu-Chang, Phi, Ji Hoon, Lee, Ji Yeoun, Lee, Chang Sik, Lee, Ju-Hee, Kim, Seung-Ki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354719/ https://www.ncbi.nlm.nih.gov/pubmed/27852054 http://dx.doi.org/10.18632/oncotarget.13265

Ejemplares similares

Panobinostat, a histone deacetylase inhibitor, suppresses leptomeningeal seeding in a medulloblastoma animal model
por: Phi, Ji Hoon, et al.
Publicado: (2017)

In vivo bioluminescence imaging for leptomeningeal dissemination of medulloblastoma in mouse models
por: Choi, Seung Ah, et al.
Publicado: (2016)

A subpopulation of cancer stem cells identifies radiographic characteristics in glioblastoma
por: Kim, Ja Eun, et al.
Publicado: (2017)

LIN28B is highly expressed in atypical teratoid/rhabdoid tumor (AT/RT) and suppressed through the restoration of SMARCB1
por: Choi, Seung Ah, et al.
Publicado: (2016)

Anti-Cancer Effects of CKD-581, a Potent Histone Deacetylase Inhibitor against Diffuse Large B-Cell Lymphoma
por: Kim, Soo Jin, et al.
Publicado: (2020)

Overcoming Chemoresistance of Pediatric Ependymoma by Inhibition of STAT3 Signaling
por: Phi, Ji Hoon, et al.
Publicado: (2015)

Moyamoya Syndrome: A Window of Moyamoya Disease
por: Phi, Ji Hoon, et al.
Publicado: (2015)

Posterior Cerebral Artery Insufficiency in Pediatric Moyamoya Disease
por: Lee, Ji Yeoun, et al.
Publicado: (2015)

CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma
por: Chang, Young, et al.
Publicado: (2020)

Indirect revascularization surgery for moyamoya disease in children and its special considerations
por: Wang, Kyu-Chang, et al.
Publicado: (2012)

The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effects
por: West, Alison C., et al.
Publicado: (2012)

Minimally Invasive Suturectomy and Postoperative Helmet Therapy : Advantages and Limitations
por: Chong, Sangjoon, et al.
Publicado: (2016)

The application of histone deacetylases inhibitors in glioblastoma
por: Chen, Rui, et al.
Publicado: (2020)

Chemokine Ligand 5 (CCL5) Derived from Endothelial Colony-Forming Cells (ECFCs) Mediates Recruitment of Smooth Muscle Progenitor Cells (SPCs) toward Critical Vascular Locations in Moyamoya Disease
por: Phi, Ji Hoon, et al.
Publicado: (2017)

M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas
por: Lee, Chanhee, et al.
Publicado: (2018)

A Novel Hydroxamic Acid-Based Curcumin Derivative as Potent Histone Deacetylase Inhibitor for the Treatment of Glioblastoma
por: Wang, Hao, et al.
Publicado: (2021)

Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma
por: Yelton, Caleb J., et al.
Publicado: (2018)

NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors
por: Phi, Ji Hoon, et al.
Publicado: (2019)

Therapeutic Potential of CKD-504, a Novel Selective Histone Deacetylase 6 Inhibitor, in a Zebrafish Model of Neuromuscular Junction Disorders
por: Jeong, Hui Su, et al.
Publicado: (2022)

Slit ventricle syndrome and early-onset secondary craniosynostosis in an infant
por: Ryoo, Hyun Gee, et al.
Publicado: (2014)

Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps
por: Fan, Wenli, et al.
Publicado: (2021)

Extracellular vesicle-associated miR-135b and -135a regulate stemness in Group 4 medulloblastoma cells by targeting angiomotin-like 2
por: Choi, Seung Ah, et al.
Publicado: (2020)

Histone Deacetylase 6 Inhibitor CKD-WID Suppressed Monosodium Urate-Induced Osteoclast Formation by Blocking Calcineurin-NFAT Pathway in RAW 264.7 Cells
por: Kim, Seong-Kyu, et al.
Publicado: (2023)

Surgical Treatment of Lesional Mesial Temporal Lobe Epilepsy
por: Chong, Sangjoon, et al.
Publicado: (2018)

Improved early development of porcine cloned embryos by treatment with quisinostat, a potent histone deacetylase inhibitor
por: TAWEECHAIPAISANKUL, Anukul, et al.
Publicado: (2018)

miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47
por: Yang, Seung Yeob, et al.
Publicado: (2015)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Correction: Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells
por: Choi, Seung Ah, et al.
Publicado: (2015)

Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells
por: Choi, Seung Ah, et al.
Publicado: (2015)

Histone Deacetylase Inhibitors Impair Glioblastoma Cell Motility and Proliferation
por: Rampazzo, Elena, et al.
Publicado: (2022)

Therapeutic potential of CKD-506, a novel selective histone deacetylase 6 inhibitor, in a murine model of rheumatoid arthritis
por: Park, Jin Kyun, et al.
Publicado: (2020)

Cavernous Malformations at Optic Apparatus: Three Cases
por: Kim, Hye Seon, et al.
Publicado: (2018)

Histone deacetylase inhibitor givinostat has ameliorative effect in the colitis model
por: Dibekoğlu, Cengiz, et al.
Publicado: (2022)

Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors
por: Lee, Su-Chan, et al.
Publicado: (2016)

EGCG-mediated autophagy flux has a neuroprotection effect via a class III histone deacetylase in primary neuron cells
por: Lee, Ju-Hee, et al.
Publicado: (2015)

Combination Treatment of CI-994 With Etoposide Potentiates Anticancer Effects Through a Topoisomerase II-Dependent Mechanism in Atypical Teratoid/Rhabdoid Tumor (AT/RT)
por: Kim, Hee Yeon, et al.
Publicado: (2021)

Cyclin-Dependent Kinase Inhibitor 2A is a Key Regulator of Cell Cycle Arrest and Senescence in Endothelial Colony-Forming Cells in Moyamoya Disease
por: Choi, Seung Ah, et al.
Publicado: (2023)

Histone Deacetylase Inhibitors Impair Vasculogenic Mimicry from Glioblastoma Cells
por: Pastorino, Olga, et al.
Publicado: (2019)

Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
por: Meng, Wei, et al.
Publicado: (2018)

A new histone deacetylase inhibitor improves liverfibrosis in BDL rats through suppression of hepatic stellate cells
por: Park, Ki Cheong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s7fd9jqasq5fuda55j6g8cj78o